A. Kato

Impaired glucose tolerance and albuminuria in patients with chronic heart failure: a subanalysis of the SUPPORT trial

I. Tsuji, T. Shiroto, H. Shimokawa, 2019, ESC heart failure.

A simple and rapid method for identification of lesions at high risk for the no-reflow phenomenon immediately before elective coronary stent implantation

H. Shimokawa, T. Kawaguchi, T. Nihei, 2016, Heart and Vessels.

The systemic inflammation-based Glasgow Prognostic Score as a prognostic factor in patients with acute heart failure

T. Takii, A. Suda, S. Namiuchi, 2015, Journal of Cardiovascular Medicine.

Elevated Plasma Homocysteine Levels and Risk of Silent Brain Infarction in Elderly People

H. Arai, S. Higuchi, Hidetada Sasaki, 2001, Stroke.

Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial

S. Ibayashi, I. Tsuji, J. Kimura, 2015, European heart journal.

Influence of Left Ventricular Ejection Fraction on the Effects of Supplemental Use of Angiotensin Receptor Blocker Olmesartan in Hypertensive Patients With Heart Failure.

S. Ibayashi, I. Tsuji, S. Miyata, 2016, Circulation journal : official journal of the Japanese Circulation Society.

Beneficial effects of long-acting nifedipine on coronary vasomotion abnormalities after drug-eluting stent implantation: The NOVEL study.

S. Miyata, H. Shimokawa, S. Yasuda, 2016, European heart journal.

Irreversible deterioration of estimated glomerular filtration rate in patients with acute myocardial infarction after primary percutaneous coronary intervention

T. Takii, S. Namiuchi, T. Sugie, 2017, Cardiovascular Intervention and Therapeutics.

Letter in reply: Glasgow Prognostic Score in heart failure, how can we use it?

S. Namiuchi, T. Sugie, A. Kato, 2016, Journal of cardiovascular medicine.